Primary age-related tauopathy
Primary age-related tauopathy (PART) is a
At autopsy, the hallmark of PART is the presence of Alzheimer-type neurofibrillary tangles (NFTs) composed of abnormal
Diagnostics
Neuropathological features
Patients with PART display
Clinical features
Patients with PART can be cognitively normal, mildly cognitively impaired, or
Furthermore,
Relationship to Alzheimer's disease
Given the similarities in the pattern of neurofibrillary tangles in PART, some scientists have argued that they represent the same phenomenon.
Genetics
PART has been associated with
Pathophysiology
MRI,
Owing to these imaging and staining advancements, tau has been identified to be associated with microtubules in neuron cells.[20] Tau protein stabilize the microtubules and are involved in fast dendrite growth, retrograde and antegrade transport intracellularly and neuron maintenance.[20]
Tau protein is divided into three segments, i.e. N-terminal (regulated spacing of microtubules), C-terminal (microtubule polymerization), proline rich domain (kinase) and microtubule binding domain.[12] Tau in brain of patients with tauopathies is hyperphosphorylated which causes the tau protein to dissociate from the microtubule then aggregate in to β-plated sheet arrangement.[12] PART cases is due to tau protein isoforms (3 and 4 microtubule binding repeats) abnormal ration inneural cells resulting in their self assembling and accumulation resulting in NFT formation in brain.[12][17][18] Detachment of tau from microtubules causes the neuron to lose its ability to sustain its self and thus ultimately loses function.
Hyper-phosphorylation of tau protein was initially thought to be caused by Aβ42 but since PART cases generally lack senile plaques, other causes were investigated. One such cause was found to me the microtubule affinity-regulating kinase (MARK) since it is involved in tau phosphorylation and dephosphorylation.
Recent finding's on tau regulation has revealed small non coding RNAs bind to recognition motifs on mRNAs and silence their expression through post-translational regulation.[21] MiRNA-219 binds to tau mRNA and represses tau protein synthesis since in fly model brain, over expression of miRNA-219 reduced the tau protein accumulation.[21]
Treatment
These options listed below have not been yet linked or specified for PART treatment since the disease is yet to gain acceptance as a unique abnormality case by the medical community. Thus the treatments represent possible future options as per the research and finding in the medical literature.
HSP90 Targets
PU-DZ8 can pass the blood brain barrier and act on HSP90 to inhibit it.[18]
Small molecule inhibitors
Staurosporine, Methylene blue and other kinase inhibitors can pass the blood brain barrier and inhibit MARK which consequently down regulation tau protein hyper-phosphorylation and ultimately its detachment from microtubules.[19]
References
- ^ "Researchers identify new neurological disorder linked to Alzheimer's" Medical news today, November 14, 2014
- ^ PMID 25348064.
- PMID 25348064.
- PMID 25628035.
- PMID 25778618.
- ^ PMID 28916532.
- ^ PMID 28160067.
- ^ PMID 22802095.
- ^ PMID 28322204.
- ^ PMID 28219440.
- PMID 28323827.
- ^ PMID 28778262.
- S2CID 33681944.
- PMID 25628035.
- PMID 25778618.
- PMID 22424230.
- ^ PMID 21047142.
- ^ PMID 17517623.
- ^ S2CID 10847883.
- ^ PMID 28077166.
- ^ PMID 25574843.